source
- FDA approves IntraBio's Aqneursa for rare ataxia-telangiectasia disorderFDA has granted approval for Aqneursa, a therapy developed by privately held biotech IntraBio, to treat ataxia-telangiectasia, a rare genetic disorder. The decision expands treatment options for pa…
- Telix to acquire German radioisotope maker ITM in deal valued up to $2.35 billionTelix Pharmaceuticals announced it will purchase ITM Isotope Technologies Munich SE, a German producer of medical radioisotopes, for an upfront payment of $1.65 billion. The transaction could rise…